By Tom Winnifrith, the Sheriff of AIM | Monday 6 December 2021
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Let’s start with a positive. Versarien (VRS) now separates its revenues and losses between graphene and non-graphene business as we have long suggested it should do. This avoids the need for Shareprophets to undertake an annual visit to Companies House to perform the analysis to reveal the low ongoing graphene sales and the scale of the losses that are being racked up in this business.